Document is current
Any future updates will be listed below
-
Authors
Benegiamo, Giorgia https://orcid.org/0000-0001-7164-6771
Bou Sleiman, Maroun
Wohlwend, Martin
Rodríguez-López, Sandra https://orcid.org/0000-0002-5088-6458
Goeminne, Ludger J. E. https://orcid.org/0000-0002-8285-7766
Laurila, Pirkka-Pekka
Klevjer, Marie https://orcid.org/0000-0001-8372-276X
Salonen, Minna K.
Lahti, Jari
Jha, Pooja
Cogliati, Sara
Enriquez, José Antonio https://orcid.org/0000-0002-3671-2961
Brumpton, Ben M. https://orcid.org/0000-0002-3058-1059
Bye, Anja
Eriksson, Johan G.
Auwerx, Johan https://orcid.org/0000-0002-5065-5393
- License Information
-
More Information
Article History
Received: 18 October 2021
Accepted: 6 September 2022
First Online: 17 October 2022
Competing interests
: J.A. is a founder and/or consultant to MitoBridge/Astellas, Metro Biotech, Amazentis, the Liver Company and NOV Metapharma. All other authors declare no competing interests.
